Apligraf

An FDA-approved living cell therapy and bioengineered skin substitute used in chronic wound care, including diabetic foot ulcers and venous leg ulcers. Denied in Michael Kissling's case across multiple appeals — a documented example of Prior Knowledge Omission resulting in progressive wound failure and eventual amputation.